Detalhe da pesquisa
1.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med
; 383(10): 931-943, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469185
2.
Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer.
J Natl Compr Canc Netw
; 21(10): 1050-1057.e13, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856197
3.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med
; 379(23): 2220-2229, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280641
4.
Evidence-based smoking cessation treatment: a comparison by healthcare system.
BMC Health Serv Res
; 21(1): 33, 2021 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413353
5.
Establishing and Evaluating an ASCO Learning Cohort: a Longitudinal Project Assessing the Learning Needs and Behaviors of Oncology Professionals.
J Cancer Educ
; 36(3): 478-483, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31741200
6.
Quantitative Assessment of Learning Behaviors for Oncology Providers.
J Cancer Educ
; 36(1): 25-32, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31377987
7.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32539942
8.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
N Engl J Med
; 376(25): 2415-2426, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28636851
9.
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Nature
; 515(7528): 563-7, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428504
10.
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Lancet Oncol
; 20(10): 1395-1408, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31422028
11.
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
Cancer
; 125(3): 382-390, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343497
12.
Low Provider Knowledge Is Associated With Less Evidence-Based Lung Cancer Screening.
J Natl Compr Canc Netw
; 17(4): 339-346, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959463
13.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
J Natl Compr Canc Netw
; 17(12): 1464-1472, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805526
14.
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.
N Engl J Med
; 372(18): 1689-99, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25923549
15.
Pembrolizumab for the treatment of non-small-cell lung cancer.
N Engl J Med
; 372(21): 2018-28, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891174
16.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(17): 1627-39, 2015 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412456
17.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
J Natl Compr Canc Netw
; 16(7): 807-821, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006423
18.
Background and rationale of the eXalt3 trial investigating X-396 in the treatment of ALK+ non-small-cell lung cancer.
Future Oncol
; 14(18): 1781-1787, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506392
19.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129443
20.
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. Reply.
N Engl J Med
; 380(9): 889-890, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811922